Bio molecular considerations in major depression and ischemic cardiovascular disease

Central Nervous System Agents in Medicinal Chemistry

Volumn 10, Issue 2, 2010, Pages 97-107

  Cocchi, Massimo ^a,b   Tonello, Lucio ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Department of Veterinary Medical Sciences   (Switzerland)

Author keywords

Consciousness; Fatty acids; Gamma synchrony; Ischemic heart disease; Major depression; Platelets; Self organizing map; Stem cell

Indexed keywords

ARACHIDONIC ACID; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; LINOLEIC ACID; OLEIC ACID; PALMITIC ACID;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID COMPOSITION; LIPID RAFT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MATHEMATICAL MODEL; PROTEIN LOCALIZATION; THROMBOCYTE; VISCOSITY;

EID: 77953659524     PISSN: 18715249     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152410791196378     Document Type: Article

References (64)

1. Coleman, M. Platelet Serotonin in Disturbed Monkeys and Children. Clin.Proc. Child. Hosp., 1971, 27, 187-194.
2. Takahashi, S. Reduction of blood platelet serotonin levels in manic and depressed patients. Folia Psychiat. Neurol. Jpn., 1976, 30, 475-486.
3. Sthal, S.M. The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch. Gen. Psychiat., 1977, 34, 509-516.
4. Kim H.L.; Plaisant O.; Leboyer, M.; Gay, C.; Kamal, L.; Devynck, M.A.; Meyer P. Reduction of platelet serotonin in major depression (endogenous depression). C. R. Acad. Sci. III, 1982, 295, 619-622.
5. Dreux, C.; Launay, J.M. Blood platelets: Neuronal Model in Psychiatric disorders. Encephale, 1985, 11, 57-64.
6. Arora, R.C.; Meltzer, H.Y. Increased serotonin 2 (5-HT2) receptor binding as measured by 3H lysergic acid diethylamide (3H-LSD) inn the blood platelets of depressed patients. Life Sci., 1989, 44, 725-734.
7. Thompson, P. Platelet and erythrocyte membrane and fluidity changes in alcohol dependent patients undergoing acute withdrawal. Alcohol Alcohol., 1999, 3, 349-354.
8. Camacho, A.; Dimsdale, J.E. Platelets and Psychiatry: Lessons learned from old and new studies. Psychosom. Med., 2000, 62, 326-336.
9. Plein, H.; Berk, M. The platelet as a peripheral marker in psychiatric illness. Clin. Exp. Pharmacol., 2001, 16, 229-236.
10. Kohonen, T. Self-Organized formation of topologically correct feature maps. Biol. Cybern., 1982, 43, 59-69.
11. Kohonen T. Self-Organizing Maps, 3rd ed.; Springer: Berlin, 2001.
12. Kohonen, T.; Kaski, S.; Somervuo, P.; Lagus, K.; Oja, M.; Paatero, V. Self-organizing map. Neurocomputing, 1998, 21, 113-122.
13. Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry, 1960, 23, 56-62.
14. Williams, J.B. A structured interview guide for the Hamilton Depression Rating Scale. Arch. Gen. Psychiatry, 1988, 45(8), 742-747.
15. Tiemeier, H.; Tuijl, H.R.; Hofman, A.; Kiliaan, A.J.; Breteler, M.M.B. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study1. Am. J. Clin. Nutr., 2003, 78, 40-6.
16. Iida, R.; Takeyama, N., Iida, N.; Tanaka, T. Characterization of overt carnitine palmitoyltransferase in rat platelets; involvement of insulin on its regulation. Mol. Cell. Biochem., 1991, 103, 23-30.
17. Passi, S.; Stancato, A.; Aleo, E.; Dmitrieva, A.; Littarru, G.P. Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. Biofactors, 2003, 18(1-4), 113-124.
18. Cocchi, M.; Tonello, L.; Bosi, S.; Cremonesi, A.; Castriota, F.; Puri, B.; Tsaluchidu S. Platelet oleic acid as ischemic cardiovascular disease marker. BMJ, 2007, Electronic letter to the editor.
19. Cocchi, M.; Tonello, L.; Cappello G. Brain, Platelets, Fatty Acids: correlations and biometabolic aspects. J. Headache Pain, 2007, 8, (suppl), Springer.
20. Cocchi, M.; Tonello, L.; Cappello, G. The use of self-organizing maps to study fatty acids in neuropsychiatric disorders. Ann. Gen. Psychiatry, 2008, 7 (suppl 1), S84
21. Cocchi, M.; Tonello, L.; Tsaluchidu, S.; Puri, B.K. The use of artificial neural networks to study fatty acids in neuropsychiatric disorders. BMC Psychiatr., 2008, 8 (Suppl 1), S3.
22. Cocchi, M.; Tonello, L. Platelet fatty acids as biochemical markers in major depression and ischemic heart disease. Nutr. Clín. Diet Hosp., 2008, 28 (supl. 1), 11.
23. Bowden, C.L. Strategies to reduce misdiagnosis of bipolar depression. Psychiatr. Ser., 2001, 52, 51-55.
24. Marangos, P.J.; Campbell, I.C.; Schmechel, D.E.; Murphy, D.L.; Goodwin, F.K. Blood platelets contain a neuron-specific enolase subunit. J. Neurochem, 1979, 34, 1254-8.
25. Cocchi, M.; Tonello, L. Platelets, fatty acids, depression and cardiovascular ischemic pathology. Progr. Nutr., 2007, 9, 94-104.
26. Sánchez-Villegas, A.; Delgado-Rodriguez M.; Alonso, A.; Schlatter, J.; Lahortiga, F.; Serra Majem, L.; Martinez-Gonzalez, M.A. Association of the Mediterranean Dietary Pattern with the Incidence of Depression. The Seguimiento Universidad de Navarra/University of Navarra Follow-up (SUN) Cohort. Arch. Gen. Psychiatry, 2009, 66 (10), 1090-1098.
27. Tiemeier, H.; van Dijck, W.; Hofman, A.; Witteman, J.C.M.; Sti-jnen, T.; Breteler, M.M.B. Relationship between atherosclerosis and late-life depression. Arch. Gen. Psychiatry, 2004, 61 (4), 369-376.
28. Musselman, D.L.; Evans, D.L.; Nemeroff, C.B. The relationship of depression to cardiovascular disease epidemiology, biology, and treatment. Arch. Gen. Psychiatry, 1998, 55, 580-592.
29. Weyers, J.; Colquhoun, D. For the OLIVE Study Group. A mediterranean diet (Med) Vs a low fat (Lf) diet improves depression independent of cholesterol in coronary heart disease patients (CHD), 2000, Poster Abstracts.
30. Donati, R.J.; Dwivedi, Y.; Roberts, R.C.; Conley, R.R.; Pandey, G.N.; Rasenick M.M. Postmortem brain tissue of depressed suicides reveals increased Gs localization in lipid raft domains where it is less likely to activate adenylyl cyclase. J. Neurosci., 2008, 28, 3042-3050.
31. Hameroff, S.R.; Penrose, R. Orchestrated reduction of quantum coherence in brain microtubules: A model for consciousness. In: S.R. Hameroff, A. Kaszniak and A.C. Scott (eds.) Toward a Science of Consciousness - The First Tucson Discussions and Debates. MIT Press Cambridge, UK, 1996, 507-540.
32. Hameroff, S.R. The conscious pilot-dendritic synchrony moves through the brain to mediate consciousness. J. Biol. Phys., 2009, Published online: doi: 10.1007/s10867-009-9148-x.
33. Alberts, B.; Bray, D.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P. Molecular Biology of the cell, Garland Publishing: CT, 1994.
34. Cowburn, R.F.; Marcusson, J.O.; Eriksson, A.; Wiehager, B.; O'Neill, C. Adenylyl cyclase activity and G-protein subunit levels in postmortem frontalcortex of suicide victims. Brain Res., 1994, 633, 297-304.
35. Pacheco, M.A.; Stockmeier, C.; Meltzer, H.Y.; Overholser, J.C.; Dilley, G.E.; Jope, R.S. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res., 1996, 723, 37-45.
36. Dowlatshahi, D.; MacQueen, G.M.; Wang, J.F.; Reiach, J.S.; Trevor Young, L. G protein-coupled cyclic AMP signaling in postmortem brain of subjectswith mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J. Neurochem., 1999, 73, 1121-1126.
37. Stewart, R.J.; Chen, B.; Dowlatshahi, D.; MacQueen, G.M.; Trevor Young, L. Abnormalities in the cAMP signaling pathway in postmortem brain tissue. Brain Res. Bull., 2001, 55, 625-629.
38. Dwivedi, Y.; Rizavi, H.S.; Conley, R.R.; Roberts, R.C.; Tamminga, C.A.; Pandey, G.N. mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims. Neuropsychopharmacology, 2002, 27, 499-517.
39. Dwivedi, Y.; Rizavi, H.S.; Shukla, P.K.; Lyons. J.; Faludi, G.; Palkovits, M.; Sarosi, A.; Conley, R.R.; Roberts, R.C.; Tamminga, C.A.; Pandey, G.N. Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol. Psychiatry, 2004, 55, 234-243.
40. Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims. Neuropsychopharmacology, 2005, 30, 1548-1556.
41. Allen, J.A.; Halverson-Tamboli, R.A.; Rasenick, M.M. Lipid raft micro domains and neurotransmitter signaling. Nat. Rev. Neurosci., 2007, 8, 128-140.
42. Mooney, J.J.; Schatzberg, A.F.; Cole, J.O.; Kizuka, P.P.; Salomon, M.; Lerbinger, J.; Pappalardo, K.M.; Gerson, B.; Schildkraut J.J. Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase. Biol. Psychiatry, 1988, 23, 543-559.
43. Garcia-Sevilla, J.A.; Padro, D.; Giralt, M.T.; Guimon, J.; Areso, P. Alpha 2-adrenoceptor-mediated inhibition of platelet adenylate cy-clase and induction of aggregation in major depression. Effect of long-term cyclic antidepressant drug treatment. Arch. Gen. Psychiatry, 1990, 47, 125-132.
44. Pandey, G.N.; Pandey, S.C.; Davis, J.M. Peripheral adrenergic receptors in affective illness and schizophrenia. Pharmacol. Toxicol., 1990, 66, 13-36.
45. Pandey, G.N.; Pandey, S.C.; Janicak, P.G.; Marks, R.C.; Davis, J.M. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol. Psychiatry, 1990, 28, 215-222.
46. Menninger, J.A.; Tabakoff, B. Forskolin-stimulated platelet adenylyl cyclase activity is lower in persons with major depression. Biol. Psychiatry, 1997, 42, 30-38.
47. Mooney, J.J.; Samson, J.A.; McHale, N.L.; Colodzin, R.; Alpert, J.; Koutsos, M.; Schildkraut, J.J. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). Biol. Psychiatry, 1998, 43, 574-583.
48. Menninger, A.; Baron, A.E.; Coningrave, K.M.; Whitfield, J.B.; Saunders, J.B.; Helander, A.; Eriksson, C.J.P.; Grant, B.; Hoffman, P.L.; Tabakoff, B. Platelet adenylyl cyclase activity as a trait marker of alcohol dependence. Alcohol Clin. Exp. Res., 2000, 24, 810-821.
49. Hines, L.M.; Tabakoff, B. Platelet adenylyl cyclase activity: a biological marker for major depression and recent drug use. Biol. Psychiatry, 2005, 58, 955-962.
50. Flynn, G.; Alexander, D., Harris, A.; Whitford, T.; Wonga, W.; Galletly, C.; Silverstein, S.; Gordon, E. Williams, L.M. Increased absolute magnitude of gamma synchrony in first-episode psychosis. Schizophr. Res., 2008, 105, 262-271.
51. Cocchi, M.; Tonello, L. Running the hypothesis of a bio molecular approach to psychiatric disorder characterization and fatty acids therapeutical choices. Ann. Gen. Psychiatry, 2010, 9(Suppl. 1): S26.
52. Rasenick. M.M.; Donati, R.J.; Popova, J.S.; Yu, J.Z. Tubulin as a regulator of G-protein signaling. Methods Enzymol., 2004, 390, 389-403.
53. Ostojic, P.; Zivojinovic, S.; Reza, T.; Milivojevic, D.; Damjanov, N. Symptoms of depression and anxiety in patients with systemic sclerosis: impact of disease severity and socioeconomic factors, 2007, THU0301. EULAR.
54. Kroft, E.B.M.; de Jong, E.M.G.J.; Evers, A.W.M. Psychological Distress in Patients with Morphea and Eosinophilic Fasciitis. Arch Dermatol, 2009, 145, 1017-1022.
55. Wernig, M.; Zhao, J.P.; Pruszak, J.; Hedlund, E.; Fu, D.; Soldner, F.; Broccoli, V.; Constantine-Paton, M.; Isacson, O.; Jaenisch, R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA, 2008, 105, 5856-5861.
56. Mackay-Sim A. Cells as Models of Brain Disorders. http://www.stemcellcentre.edu.au/Research/Collaborative_Streams/ Stream_2/Stream2Module5.asp
57. Mullis, K.B.; Interview by Marco Pivato. Ma la depressione é nel sangue. La Stampa, TuttoScienze, 2008, October 1, V.
58. Hameroff, S.R. Interview by Marco Pivato. Ma la depressione é nel sangue. La Stampa, Tuttoscienze, 2008, October 1, V.
59. McEwen, B.S. Stress and hippocampal plasticity. Annu. Rev. Neu- rosci., 1999, 22, 105-122.
60. Duman, S.R.; Malberg, J.; Nagakawa, S.; D'Sa, C: Neuronal plasticity and survival in mood disorder. Biol. Psychiatry, 2000, 48, 732-739.
61. Chaouloff, F. Serotonin, stress and corticoids. J. Psychopharm., 2000, 14, 139-151.
62. Bianchi, M.; Heidbreder, C.; Crespi, F. Cytoskeletal changes in the hippocampus following restraint stress: Role of serotonin and mi-crotubules. Synapse, 2003, 49, 188-194.
63. Popova, J.S.; Greene, A.K.; Wang, J.; Rasenick, M.M. Phosphati-dylinositol 4, 5-bisphosphate modifies tubulin participation in phospholipase Cß1 signaling. J. Neurosci., 2002, 22, 1668-1678.
64. Quilter, C.L.; Gilbert, C.L.; Oliver, G.L.; Jafer, O.; Furlong, R.A.; Blott, S.C.; Wilson, A.E.; Sargent, C.A.; Mileham, A.; Affara, N.A. A Model for puerperal psychosis. Am. J. Med. Genet. B Neuropsy-chiatr. Genet, 2008, 147, 1126-1137.